How I treat autoimmune neutropenia in adults
Listen to this summary
The authors aim to address the management of autoimmune neutropenia (AiN) in adults, a rare condition that is often chronic and typically asymptomatic despite low neutrophil counts. They highlight the challenges in treatment due to the variable clinical presentation and the unclear mechanisms behind neutrophil destruction, suggesting that observation and supportive care are usually preferred. The paper discusses potential treatment strategies, including boosting neutrophil production and targeting immune-mediated destruction, while emphasizing the need for collaborative efforts to improve treatment approaches for this condition.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Blood
View all →Aug 6, 2026 · Blood
Expansion of functional human long-term HSCs through restraining excessive cell cycle activation
Aug 6, 2026 · Blood
A quantitative definition of the clinical manifestations of GATA2 deficiency in adults
Aug 6, 2026 · Blood
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study
Aug 4, 2026 · Blood
Functional restoration of immune defects in STAT1 gain-of-function disease following stem cell gene editing
Aug 4, 2026 · Blood
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma
Aug 4, 2026 · Blood
Boosting anti-leukemia cytotoxicity of CD4 and CD8 T cells through combined inhibition of MEK and HDAC
More in Internal Medicine
View all →Aug 9, 2026 · American heart journal
Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial
Aug 8, 2026 · JACC. Clinical electrophysiology
LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block
Aug 8, 2026 · JACC. Clinical electrophysiology
Atrial Fibrillation Initiation Arises From Reentry at Patient-Specific Regions With Steep Repolarization Gradients Identified During Sinus Rhythm
Aug 7, 2026 · American heart journal
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics
Aug 7, 2026 · The American journal of medicine
Consumption of Ultra-Processed Foods and Increased Risks of Prostate Cancer in a Random Sample of United States Adults
Aug 7, 2026 · JACC. Clinical electrophysiology
The Emergence of Sports Electrophysiology: Care of Athletes With Arrhythmias, From the ACC's Sports and Exercise Cardiology Leadership Council
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


